Research Directory

The stakes for biopharma from German drug policy

Read more

The EU Clinical Trials Directive - Debate over new legislation reaches final stage

Read more

The EU Transparency Directive: Further debate on market access

Read more

Value-based drug pricing coming soon in UK

Read more

Managers ignore pharmacovigilance at their peril

Read more

Adaptive licensing: A new approach for drug approvals

Read more

IMI: As Big Pharma pulls back, IMI steps in

Read more

MRC Technology: Going global for local returns

Read more

EU Transparency Directive: changes afoot on pricing and reimbursement

Read more

How to strengthen the biopharma ecosystem

Read more